Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community

OBJECTIVES:. To characterize regulatory and clinical adoption challenges to developing host-based sepsis diagnostics and to establish a common framework for stakeholders to work together toward potential solutions to these challenges. DESIGN:. Expert review, structured interviews, and small group di...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael T. McCurdy, MD, FCCM, Timothy E. Sweeney, MD, PhD, Debra Foster, BSc, Bobby Reddy, Jr, PhD, Steven Q. Simpson, MD, for Sepsis Alliance and the Infection Management and Sepsis Collaborative Community (IMSCC) Panelists, Sandy Cayo, Matthew Churpek, Shannon Davila, Paul Epner, Jon Glaudemans, Helen Haskell, Thomas Heymann, Nina Hill, Cindy Hou, Ashish Khanna, Marianne Kraemer, Greg Martin, Emi Minejima, Nicholas Mohr, Anurag Patel, Christa Schorr, Uzma Syed, Andre Vovan
Format: Article
Language:English
Published: Wolters Kluwer 2025-08-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000001293
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849222750200135680
author Michael T. McCurdy, MD, FCCM
Timothy E. Sweeney, MD, PhD
Debra Foster, BSc
Bobby Reddy, Jr, PhD
Steven Q. Simpson, MD
for Sepsis Alliance and the Infection Management and Sepsis Collaborative Community (IMSCC) Panelists
Sandy Cayo
Matthew Churpek
Shannon Davila
Paul Epner
Jon Glaudemans
Helen Haskell
Thomas Heymann
Nina Hill
Cindy Hou
Ashish Khanna
Marianne Kraemer
Greg Martin
Emi Minejima
Nicholas Mohr
Anurag Patel
Christa Schorr
Uzma Syed
Andre Vovan
author_facet Michael T. McCurdy, MD, FCCM
Timothy E. Sweeney, MD, PhD
Debra Foster, BSc
Bobby Reddy, Jr, PhD
Steven Q. Simpson, MD
for Sepsis Alliance and the Infection Management and Sepsis Collaborative Community (IMSCC) Panelists
Sandy Cayo
Matthew Churpek
Shannon Davila
Paul Epner
Jon Glaudemans
Helen Haskell
Thomas Heymann
Nina Hill
Cindy Hou
Ashish Khanna
Marianne Kraemer
Greg Martin
Emi Minejima
Nicholas Mohr
Anurag Patel
Christa Schorr
Uzma Syed
Andre Vovan
author_sort Michael T. McCurdy, MD, FCCM
collection DOAJ
description OBJECTIVES:. To characterize regulatory and clinical adoption challenges to developing host-based sepsis diagnostics and to establish a common framework for stakeholders to work together toward potential solutions to these challenges. DESIGN:. Expert review, structured interviews, and small group discussions with experienced clinicians and experts in diagnostic test development and regulatory issues. SETTING:. A series of large and small group conference calls conducted from January 2023 to September 2024, along with a review of the available evidence and scope of the issue. SUBJECTS:. A collaborative group of multinational and multidisciplinary sepsis-focused patient advocacy groups, academic research groups, regulatory experts, and executives and clinical leaders from private companies assembled by Sepsis Alliance’s Infection Management and Sepsis Collaborative Community. INTERVENTIONS:. The implications of existing regulatory practices surrounding the evaluation of host-based sepsis diagnostics were examined using structured, small group interviews and discussions. The entire expert panel collated the findings of small groups, and consensus was achieved on the most salient points. MEASUREMENTS AND MAIN RESULTS:. For various reasons, current regulatory practices surrounding host-based sepsis diagnostics pose significant challenges to both regulators and product developers in creating optimal clinical tools. The most important barriers to regulatory approval were considered to be: classification of the diagnostic tests’ goals and output, heterogeneity of sepsis presentation and course, and lack of universal definitions of sepsis. Potential solutions to the challenges were informally proposed, but were not explored rigorously at this project phase. CONCLUSIONS:. A collaborative statement was created outlining the challenges of developing diagnostic tests and devices for sepsis, including existing regulatory requirements surrounding host-based sepsis diagnostics and their implications for ultimate clinical deployment. Characterizing these challenges is a necessary first step to establish a common framework for stakeholders to effectively engage in discussions to develop potential solutions.
format Article
id doaj-art-0e4e01dae5e647fa83021fa290891725
institution Kabale University
issn 2639-8028
language English
publishDate 2025-08-01
publisher Wolters Kluwer
record_format Article
series Critical Care Explorations
spelling doaj-art-0e4e01dae5e647fa83021fa2908917252025-08-26T03:23:45ZengWolters KluwerCritical Care Explorations2639-80282025-08-0178e129310.1097/CCE.0000000000001293202508000-00005Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative CommunityMichael T. McCurdy, MD, FCCM0Timothy E. Sweeney, MD, PhD1Debra Foster, BSc2Bobby Reddy, Jr, PhD3Steven Q. Simpson, MD4for Sepsis Alliance and the Infection Management and Sepsis Collaborative Community (IMSCC) PanelistsSandy CayoMatthew ChurpekShannon DavilaPaul EpnerJon GlaudemansHelen HaskellThomas HeymannNina HillCindy HouAshish KhannaMarianne KraemerGreg MartinEmi MinejimaNicholas MohrAnurag PatelChrista SchorrUzma SyedAndre Vovan1 Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD.2 Inflammatix, Sunnyvale, CA.3 Spectral Medical, Toronto, ON.4 Prenosis, Chicago, IL.5 Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, Kansas City, KS.OBJECTIVES:. To characterize regulatory and clinical adoption challenges to developing host-based sepsis diagnostics and to establish a common framework for stakeholders to work together toward potential solutions to these challenges. DESIGN:. Expert review, structured interviews, and small group discussions with experienced clinicians and experts in diagnostic test development and regulatory issues. SETTING:. A series of large and small group conference calls conducted from January 2023 to September 2024, along with a review of the available evidence and scope of the issue. SUBJECTS:. A collaborative group of multinational and multidisciplinary sepsis-focused patient advocacy groups, academic research groups, regulatory experts, and executives and clinical leaders from private companies assembled by Sepsis Alliance’s Infection Management and Sepsis Collaborative Community. INTERVENTIONS:. The implications of existing regulatory practices surrounding the evaluation of host-based sepsis diagnostics were examined using structured, small group interviews and discussions. The entire expert panel collated the findings of small groups, and consensus was achieved on the most salient points. MEASUREMENTS AND MAIN RESULTS:. For various reasons, current regulatory practices surrounding host-based sepsis diagnostics pose significant challenges to both regulators and product developers in creating optimal clinical tools. The most important barriers to regulatory approval were considered to be: classification of the diagnostic tests’ goals and output, heterogeneity of sepsis presentation and course, and lack of universal definitions of sepsis. Potential solutions to the challenges were informally proposed, but were not explored rigorously at this project phase. CONCLUSIONS:. A collaborative statement was created outlining the challenges of developing diagnostic tests and devices for sepsis, including existing regulatory requirements surrounding host-based sepsis diagnostics and their implications for ultimate clinical deployment. Characterizing these challenges is a necessary first step to establish a common framework for stakeholders to effectively engage in discussions to develop potential solutions.http://journals.lww.com/10.1097/CCE.0000000000001293
spellingShingle Michael T. McCurdy, MD, FCCM
Timothy E. Sweeney, MD, PhD
Debra Foster, BSc
Bobby Reddy, Jr, PhD
Steven Q. Simpson, MD
for Sepsis Alliance and the Infection Management and Sepsis Collaborative Community (IMSCC) Panelists
Sandy Cayo
Matthew Churpek
Shannon Davila
Paul Epner
Jon Glaudemans
Helen Haskell
Thomas Heymann
Nina Hill
Cindy Hou
Ashish Khanna
Marianne Kraemer
Greg Martin
Emi Minejima
Nicholas Mohr
Anurag Patel
Christa Schorr
Uzma Syed
Andre Vovan
Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community
Critical Care Explorations
title Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community
title_full Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community
title_fullStr Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community
title_full_unstemmed Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community
title_short Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community
title_sort challenges facing developers of diagnostic tests for sepsis a report from sepsis alliance and the infection management and sepsis collaborative community
url http://journals.lww.com/10.1097/CCE.0000000000001293
work_keys_str_mv AT michaeltmccurdymdfccm challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT timothyesweeneymdphd challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT debrafosterbsc challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT bobbyreddyjrphd challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT stevenqsimpsonmd challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT forsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunityimsccpanelists challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT sandycayo challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT matthewchurpek challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT shannondavila challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT paulepner challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT jonglaudemans challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT helenhaskell challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT thomasheymann challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT ninahill challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT cindyhou challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT ashishkhanna challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT mariannekraemer challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT gregmartin challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT emiminejima challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT nicholasmohr challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT anuragpatel challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT christaschorr challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT uzmasyed challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity
AT andrevovan challengesfacingdevelopersofdiagnostictestsforsepsisareportfromsepsisallianceandtheinfectionmanagementandsepsiscollaborativecommunity